UK Outlook 2018: Companies Need To Quantify Brexit Risk And Find A New Place In The World
Executive Summary
With the clock running down on Brexit, bemused UK medtechs are ready to seize any information that helps them chart a way forward on trading with the EU in the absence of solid directions from the government. Frustrated by the Brexit vacuum, local manufacturers are actively looking to build businesses beyond the EU and focusing on innovation adoption at home, as ABHI policy director Richard Phillips explains.
You may also be interested in...
UK Medtechs Stress Need To Get It Right On Brexit As Prime Minister Addresses EU
Coinciding with UK prime minister Theresa May's third major speech on her Brexit vision for the UK, the local medtech industry has taken the opportunity to stress the vital need for sensible, workable trading arrangements governing UK-EU health-care supply chains after March 2019.
NHS Medtech Demand-Side Should Be Greater Priority, Says UK Industry In AAR Response
The Accelerated Access Review, part of the UK's renewed push to speed access to innovations for system efficiency, cost savings and outcomes improvements, strikes most of the right notes, but there is still room for improvement in the framework of innovation adoption by the NHS, according to an industry-commissioned response to the review.
UK Medtech Rises Up To Meet The Challenges Of Brexit
How the UK medtech industry can forge successful international relationships, increase health-care delivery efficiency and improve patient outcomes following Brexit are the challenges taken up by the Association of British Healthcare Industries in a new report.